Patents by Inventor Jeremy David Alistair Kitson

Jeremy David Alistair Kitson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL LIGAND
    Publication number: 20150197565
    Abstract: The invention provides an isolated protein which is a member of the TNF ligand superfamily and comprises: i) a polypeptide having the amino acid sequence of FIG. 1; or ii) a variant of the polypeptide of i).
    Type: Application
    Filed: July 17, 2014
    Publication date: July 16, 2015
    Applicant: Glaxo Group Limited
    Inventors: Stuart Neville FARROW, Allard Kaptein, Jeremy David Alistair Kitson, Alison J. Winder
  • Method for inhibiting binding to B-cell receptor
    Patent number: 8784814
    Abstract: The invention provides an isolated protein which is a member of the TNF ligand superfamily and comprises: i) a polypeptide having the amino acid sequence of figure (1); or ii) a variant of the polypeptide of i).
    Type: Grant
    Filed: June 28, 2012
    Date of Patent: July 22, 2014
    Assignee: Glaxo Group Limited
    Inventors: Stuart Neville Farrow, Allard Kaptein, Jeremy David Alistair Kitson, Alison J. Winder
  • Method for inhibiting binding to B-cell receptor
    Patent number: 8216576
    Abstract: The invention provides an isolated protein which is a member of the TNF ligand superfamily and comprising: i) a polypeptide having the amino acid sequence of FIG. 1; or ii) a variant of the polypeptide of i).
    Type: Grant
    Filed: May 8, 2007
    Date of Patent: July 10, 2012
    Assignee: Glaxo Group Limited
    Inventors: Stuart Neville Farrow, Allard Kaptein, Jeremy David Alistair Kitson, Alison J. Winder